Diclo KD

Quick links to important sections

Medically reviewed

Rosario Oropesa

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Diclo KD

Quick Facts

Property Description
Active Ingredient Diclofenac potassium
Form Oral Solid Dosage (e.g., tablet)
Pharmacological Class Nonsteroidal Anti-Inflammatory Drug (NSAID)
General Purpose Relief of pain and inflammation
Origin Synthetic Phenylacetic Acid Derivative

Classification and Active Ingredient

Diclo KD is a medication containing the active substance diclofenac potassium (INN), which is classified as a Nonsteroidal Anti-Inflammatory Drug (NSAID). This medicine is a synthetic derivative belonging to the phenylacetic acid derivative group. The core identity of Diclo KD is defined by its triple action: functioning simultaneously as an anti-inflammatory agent, an analgesic (pain reliever), and an antipyretic (fever reducer). As an NSAID, its primary purpose is addressing both the subjective sensation of pain and the objective signs of inflammation, providing a comprehensive approach to managing acute discomfort.


Understanding Diclofenac Potassium and Its Form

The active composition of the drug is diclofenac potassium, a precise chemical entity typically delivered in an oral solid dosage form. The specific use of the potassium salt is a key differentiator, distinguishing this preparation from related versions like diclofenac sodium. The use of the potassium salt facilitates rapid absorption of the medicine after oral administration, ensuring a relatively quick onset of action. This rapid action is beneficial when fast relief of acute discomfort is needed. Diclo KD is formulated as a single-ingredient product, focusing its therapeutic effect entirely on the properties of diclofenac.


Core Purpose: General Relief of Pain and Inflammation

The medicine's general purpose is to provide rapid symptomatic relief by intervening directly in the chemical processes that cause discomfort, swelling, and fever. The foundational principle behind this relief is the inhibition of prostaglandin synthesis, as prostaglandins are the lipid compounds responsible for mediating the body's inflammatory and pain responses. Diclofenac achieves this by acting as a cyclooxygenase inhibitor, effectively blocking the enzyme responsible for producing these messengers. By temporarily blocking the production of these key chemical messengers, Diclo KD works systemically to reduce the associated signs of inflammation and the intensity of pain. This foundational action defines the medicine's role in the rapid, general management of discomfort.

Regulatory References

  1. Diclofenac: MedlinePlus Drug Information

What side effects are possible with Diclo KD?

Possible Side Effects and Safety Information

Diclo KD contains diclofenac, a non-steroidal anti-inflammatory drug (NSAID). Like all systemic NSAIDs, its use is associated with a class risk of serious adverse events, particularly affecting the cardiovascular and gastrointestinal systems.


Serious and Clinically Significant Risks

  • Cardiovascular Thrombotic Events: Official warnings highlight an increased risk of serious, potentially fatal, myocardial infarction (MI) and stroke. This risk may increase with the duration of use and higher doses. Diclo KD is contraindicated for treating perioperative pain in the setting of Coronary Artery Bypass Graft (CABG) surgery and in patients with established congestive heart failure (NYHA class II-IV), ischemic heart disease, peripheral arterial disease, or cerebrovascular disease.
  • Gastrointestinal Adverse Events: NSAIDs can cause serious events, including bleeding, ulceration, and perforation of the stomach or intestines, which may occur without warning symptoms and can be fatal. The risk is higher in elderly patients.
  • Hepatotoxicity and Renal Toxicity: Diclofenac may cause elevations in liver enzymes and can lead to serious liver or kidney problems, including acute renal failure and papillary necrosis.
  • Hypersensitivity: Rare but serious reactions, including anaphylaxis and severe skin conditions like Stevens-Johnson syndrome (SJS) and Toxic Epidermal Necrolysis (TEN), have been reported.

Common Adverse Reactions

Common side effects (occurring in ge 1% of patients) generally involve the gastrointestinal system and include nausea, dyspepsia, vomiting, abdominal pain, diarrhea, and constipation. Other common reactions include headache, dizziness, and edema (fluid retention).


Safety Considerations

To mitigate risks, official regulatory guidance mandates using the lowest effective dose for the shortest duration necessary for symptom control. Monitoring of blood pressure, renal function, and hepatic function is often recommended during treatment, especially in patients with pre-existing risk factors. Use of Diclo KD should be avoided from about 30 weeks of pregnancy due to the risk of premature closure of the fetal ductus arteriosus.

Overdose and Emergency Response

Overdose and when to seek help

The official regulatory documentation for diclofenac potassium defines specific manifestations and actions required in the event of an overdose.

Documented Overdose Manifestations and Severe Outcomes

Classification Official Regulatory Wording
Documented Overdose Presentations Symptoms include gastrointestinal disturbances (nausea, vomiting, diarrhea, stomach pain), and CNS effects such as headache, drowsiness, confusion, dizziness, blurred vision, and tinnitus.
Severe Outcomes Overdose may lead to acute renal failure, gastrointestinal bleeding, convulsions, metabolic acidosis, and major cardiovascular changes (hypertension or hypotension).

Emergency Actions and Management

Seek emergency medical attention right away if an overdose is suspected or if severe symptoms occur. Immediate medical help is required for signs such as chest pain, shortness of breath or trouble breathing, weakness in one part of the body, slurred speech, or swelling of the face or throat. Contact a Poison Control Center immediately.

No specific antidote is known for diclofenac potassium. Treatment is symptomatic and supportive, and may include the administration of activated charcoal and monitoring of vital signs and laboratory tests. A large overdose is officially documented as being very harmful to both children and adults. Hospital observation may be required.

Therapeutic Uses of Diclo KD

What Diclo KD Treats: Main Uses and Benefits

Diclo KD is generally used to help manage symptoms related to physical discomfort and inflammatory states across several key domains, providing supportive relief in various clinical contexts. The medicine is commonly used for the symptomatic relief of conditions such as osteoarthritis, rheumatoid arthritis, and primary dysmenorrhea (menstrual pain), alongside the management of acute pain and fever.


The medication is applied in addressing symptom clusters related to inflammatory or irritative states, specifically reducing pain, swelling, and stiffness associated with these conditions. This supportive action helps improve day-to-day comfort and assists with managing the overall symptom load during disease flares.

“This assistance supports the patient during difficult episodes by easing distress and provides supportive relief when symptoms interfere with routine activities.”

Diclo KD is relevant when supportive symptom management is appropriate, often used during phases when symptoms become more noticeable, such as after post-traumatic injuries or during acute migraine headaches. This temporary symptomatic assistance contributes to easing the overall symptom load, and may help patients cope with symptom fluctuations.


Quick Fact: Symptom Management

The medication's role is relevant in managing symptoms related to inflammatory or irritative states, especially those involving both pain and inflammation. It is relevant in contexts marked by increased discomfort or tension.

Regulatory References

  1. DailyMed (National Institutes of Health)

Eligibility and Restrictions for Use

Who Can and Cannot Use Diclo KD

Diclo KD (Diclofenac Potassium) is subject to specific population eligibility rules defined by official regulatory authorities. Use is absolutely contraindicated in patients with severe, pre-existing conditions, specific allergies, or during certain physiological states.


Absolute Contraindications

The medicine must not be used by individuals who have:

  • A known hypersensitivity to diclofenac or other components.
  • A history of allergic reactions (e.g., asthma, hives) after taking aspirin or other Nonsteroidal Anti-Inflammatory Drugs (NSAIDs).
  • Active gastrointestinal ulceration, bleeding, or perforation.
  • Severe cardiac failure (NYHA Class II-IV) or severe hepatic/renal failure.
  • Peri-operative pain in the setting of Coronary Artery Bypass Graft (CABG) surgery.
  • Are in the last trimester of pregnancy (after 30 weeks gestation).

Population Restrictions

Population Group Regulatory Status
Pediatric Not recommended for children typically below 14 years of age.
Geriatric Use requires particular caution due to increased risk of serious adverse reactions.
Pregnancy Contraindicated in the last trimester; conditional use in earlier trimesters.
Lactation Not recommended by some authorities due to potential for infant exposure.
Cardiovascular Risk Use is generally not recommended for patients with established heart disease or significant risk factors.

Individuals with mild-to-moderate renal or hepatic impairment or a history of gastrointestinal disorders have a conditional eligibility status and require close medical monitoring.

What should I know about interactions with other medicines?

Diclo KD Interactions with other medicines and products

Official regulatory documents define the product's interaction profile based on pharmacokinetic and pharmacodynamic outcomes, leading to specific use restrictions. The main metabolic pathway is clearance via the CYP2C9 enzyme, meaning strong inhibitors, such as Voriconazole, are documented to significantly increase the systemic exposure (Cmax and AUC) of Diclo KD.


Interaction Classifications

Classification Description based on Official Regulatory Documents
Interaction Severity Contraindicated Combination (e.g., perioperative use in CABG surgery); Clinically Significant Interaction (e.g., additive GI risk, increased plasma concentrations of co-administered drugs).
Regulatory Basis U.S. FDA, DailyMed, and European SmPC.
Interaction-Context Constraints Procedural constraint: Contraindicated for perioperative pain in the setting of Coronary Artery Bypass Graft (CABG) surgery.

Official Interaction Statements

  • Other NSAIDs, Anticoagulants (Warfarin), Oral Corticosteroids, SSRIs, and SNRIs: These combinations increase the additive pharmacodynamic risk of serious gastrointestinal ulceration and bleeding.
  • ACE Inhibitors, ARBs, and Diuretics: Co-administration may diminish the antihypertensive or natriuretic effect and can heighten the risk of compromised renal function.
  • Lithium, Digoxin, Methotrexate, and Cyclosporine: Concomitant use can increase the plasma concentrations and potential for toxicity of these agents.
  • Alcohol: The use of alcohol is officially listed as a factor that increases the risk for serious GI bleeding.

The regulatory profile highlights a substantial additive risk with agents that affect bleeding or the GI tract. The interaction notes establish that the risk of renal function deterioration is specifically heightened for elderly, volume-depleted, or renal-impaired patients when co-administered with ACE Inhibitors or ARBs.

Mechanism of Action

Inhibition of Eicosanoid Biosynthesis

Diclo KD (Diclofenac Potassium) operates by targeting specific enzyme systems to modulate physiological processes involving eicosanoids. The active substance's potassium salt form facilitates the rapid achievement of effective concentration at the target site. The drug's fundamental action is the non-selective, reversible inhibition of Cyclooxygenase (COX) enzymes, including both the inducible COX-2 and constitutive COX-1 isoforms. By binding to the COX active site, Diclo KD suppresses the upstream synthesis of prostaglandins and other lipid mediators derived from the arachidonic acid cascade. This molecular intervention affects the chemical cascade that regulates inflammatory physiological responses throughout the body.


Attenuation of Peripheral and Central Signaling

This mechanism results in the reduction of local prostaglandins, particularly PGE2, which normally sensitizes nociceptors (pain-sensing nerve endings). Its suppression elevates the functional threshold for activation, regulating afferent signal transmission in the peripheral nervous system. Additionally, PGE2 production is suppressed within the hypothalamic thermoregulatory center. This mechanism directly influences the brain region controlling core body temperature, leading to the resetting of the elevated temperature set point and initiating heat loss mechanisms.

Dosage and Administration Information

How to Use Diclo KD

Diclo KD, which contains diclofenac potassium, is strictly administered via the oral route as an immediate-release tablet, liquid-filled capsule, or powder for oral solution. The general principle governing its use is to utilize the lowest effective dose for the shortest duration necessary to address the patient’s condition.


Dosing and Frequency Patterns

The medicine is used either in divided daily doses for recurring conditions or as an as-needed (PRN) single dose for acute episodes. For conditions such as osteoarthritis or rheumatoid arthritis, the total daily dose typically ranges from 100 mg to 200 mg taken in multiple, divided amounts (e.g., two to four times daily). For the specific indication of acute migraine, the oral solution form is used as a single 50 mg dose. Doses are not to be substituted between formulations on a milligram-for-milligram basis, as different oral forms are not bioequivalent.


Administration Conditions

Administration instructions are dependent on the specific formulation. Immediate-release tablets may be taken with or without food. However, the powder for oral solution intended for acute use requires administration on an empty stomach (at least 1 hour before or 2 hours after a meal) for optimal absorption. Furthermore, the powder must be immediately mixed with only 30 to 60 mL of water prior to consumption. Patients must swallow tablets and capsules whole, without crushing or chewing the medication. If a dose is missed, the general approach is to skip that dose and resume the normal schedule if it is almost time for the next dose, rather than doubling up.


Population-Specific Use

Certain diclofenac potassium products are approved for use in patients 12 years of age and older. For those with hepatic impairment, a reduced starting dose may be necessary due to the liver's role in the drug's elimination, although no specific adjustment is noted for mild to moderate renal dysfunction.

Recent Clinical Evidence

Diclo KD: Recent Clinical Evidence

Research on diclofenac potassium (Diclo KD) focuses on its effectiveness in relieving various types of mild to moderate acute pain and inflammation. As an immediate-release nonsteroidal anti-inflammatory drug (NSAID), Diclo KD is designed for rapid absorption, which is key to its use in acute pain management.


Efficacy in Acute Pain

Clinical trials, including numerous randomized, double-blind, placebo-controlled studies, have evaluated Diclo KD across multiple acute pain scenarios. The evidence supports its use for the short-term treatment of:

  • Acute Pain: Pain following dental extractions or minor surgery.
  • Headache and Migraine: Relief from symptoms of tension headaches and acute migraine attacks.
  • Dysmenorrhea: Pain associated with menstrual cramps.
  • Cold and Flu Symptoms: Associated pain, fever, and sore throat.

Studies consistently report a rapid onset of pain relief compared to standard diclofenac sodium formulations. Pharmacokinetic analysis indicates that the median time to reach maximum concentration is typically around 30 minutes after oral administration, allowing for prompt analgesic effect.


Comparative and Long-term Data

Comparative studies have been conducted to evaluate the efficacy of Diclo KD against other common over-the-counter analgesics. For instance, data from clinical trials suggest that a single dose of 25 mg Diclo KD is comparable to a single dose of 400 mg ibuprofen in providing pain relief.

Condition Studied Key Research Finding (Summary)
Postoperative Pain Studies suggest Diclo KD is associated with a lower Number Needed to Treat (NNT) for significant pain relief compared to placebo.
Cardiovascular Risk The overall risk of serious cardiovascular events with diclofenac, like other NSAIDs, is generally associated with high dose and prolonged, continuous use.

Long-term surveillance studies examine safety outcomes in participants using Diclo KD. These reviews are important for monitoring potential risks, such as gastrointestinal irritation or bleeding, which are common to the NSAID class, particularly with extended or high-dose usage.

Frequently Asked Questions (FAQ)

Common questions about Diclo KD (FAQ)

Q: What is the main difference between Diclo KD and regular diclofenac?

Diclo KD contains the potassium salt of diclofenac, whereas other versions often use the sodium salt. Official product information states that the potassium salt formulation is designed for rapid absorption, meaning it reaches effective levels in the bloodstream quicker than diclofenac sodium. This rapid absorption is the key feature that makes Diclo KD suitable for the relief of acute pain.

Q: Why is Diclo KD sometimes called the 'fast-acting' version?

It is referred to as 'fast-acting' because the use of the potassium salt in the formulation allows the medicine to be absorbed faster from the digestive tract. According to regulatory documents, this helps the drug quickly reach its maximum concentration in the blood, which is associated with a rapid onset of analgesic effect.

Q: How long does the pain relief from Diclo KD typically last?

The duration of pain relief from a single dose is generally inferred from the regulatory dosing schedules. Dosing frequency for certain acute uses is often set at intervals of every 4 to 6 hours, which provides context for the expected duration of a single dose's effect.

Q: Can Diclo KD be taken on an empty stomach?

Administration conditions vary by formulation. Immediate-release tablets may be taken with or without food. However, the powder for oral solution intended for rapid relief is generally required to be administered on an empty stomach to ensure optimal absorption.

Q: What's the difference in how Diclo KD is absorbed versus a standard pill?

The key difference is the speed of absorption. Diclo KD, which uses the potassium salt, is absorbed faster than standard diclofenac sodium pills. Studies indicate that while the total amount of drug absorbed may be similar, the time it takes to reach maximum concentration in the bloodstream is significantly shorter with the potassium salt formulation.

Q: Does taking Diclo KD regularly affect future responses to the medication?

According to official drug information, studies have shown that the pharmacokinetics (how the body processes the drug) of Diclo KD are generally unaltered following multiple administrations. This indicates that significant drug accumulation does not occur when the medicine is used within the recommended dose range.

Q: Can Diclo KD be used for a simple tension headache?

Diclo KD is indicated for specific types of acute pain, including the relief of symptoms from acute migraine attacks. However, a simple tension headache is not listed as a specific official indication in the current regulatory prescribing information.

Q: Does Diclo KD make you feel drowsy or affect driving?

Official warnings mention that dizziness is a common side effect reported by patients. Because of the risk of dizziness, this medication may potentially affect a person's ability to drive or operate machinery. Individuals may need to observe their reaction to the drug before engaging in such activities.

Q: What happens if I miss a scheduled dose of Diclo KD?

Regulatory guidance advises that if a dose is missed, individuals should generally skip the missed dose and resume the normal schedule at the next scheduled time. Taking a double dose to compensate for a missed one is generally not recommended.

Q: Are there any foods or drinks that make Diclo KD less effective?

For the powder-for-solution formulation, taking the medicine with food can significantly delay absorption and potentially reduce the effectiveness of the rapid relief. For all formulations, adhering to the administration instructions (with or without food, or on an empty stomach) is necessary to ensure the drug performs as intended.

Q: What research supports the effectiveness of the 'KD' formulation in Diclo KD?

Regulatory documents cite research that highlights the faster absorption rate of the potassium salt, which is considered a key factor contributing to its suitability for rapid action in acute pain. Pharmacokinetic studies show peak concentrations are reached rapidly after administration.

Q: Does Diclo KD build up in your system over time?

No, studies indicate that Diclo KD (diclofenac) has a short terminal half-life. Official regulatory documents indicate that significant drug accumulation does not occur in the body when the drug is used within the recommended dose range.

Q: What is the longest period of time someone can safely take Diclo KD?

For over-the-counter (OTC) products, the duration of use is often strictly limited, such as a maximum of three days for acute symptoms. For prescription use, the duration of treatment is based on the specific medical condition being addressed.

Q: Does Diclo KD cause water retention or swelling?

Yes, regulatory warnings note that fluid retention and edema (swelling) have been observed with NSAIDs like Diclo KD. Due to this potential side effect, caution is advised when the medicine is used by individuals with fluid retention or heart failure.

Q: Why is the potassium salt used in Diclo KD instead of the sodium salt?

The potassium salt is specifically used in the formulation because regulatory studies show it allows for a significantly faster rate of absorption compared to the sodium salt. This rapid absorption is the key characteristic that makes Diclo KD suitable for the quick relief of acute pain.

Q: Is Diclo KD the same drug as Cataflam?

Diclo KD is the active ingredient diclofenac potassium. Cataflam was a former brand name used for immediate-release diclofenac potassium tablets in some markets.

Q: Are allergic reactions to Diclo KD common?

While anaphylactic reactions and other severe allergic skin reactions are reported, official product information classifies them as rare serious adverse events. However, use is strictly contraindicated in anyone with a known history of allergic reactions to aspirin or other NSAIDs.

Q: What are the non-pain-related benefits of Diclo KD?

In addition to its analgesic effect (pain relief), official regulatory documents confirm that Diclo KD also acts as an anti-inflammatory agent to reduce swelling, and it has antipyretic properties, meaning it can help reduce fever.

Q: Is it okay to crush or chew Diclo KD tablets?

Official regulatory instructions state that patients must swallow tablets and capsules whole. The medicine is not to be crushed, broken, or chewed prior to swallowing, as this could compromise its intended immediate-release characteristics.

Q: How does Diclo KD affect prostaglandin production?

Diclo KD works by acting as an inhibitor of the cyclooxygenase (COX) enzymes in the body. By blocking these enzymes, the drug effectively suppresses the synthesis of prostaglandins, which are the chemical messengers responsible for mediating pain and inflammation.

Q: Do studies show Diclo KD is absorbed faster in younger vs. older people?

Official information indicates that the overall pharmacokinetics of diclofenac are generally not impaired to any clinically relevant extent in the elderly. However, increased caution is recommended for older individuals due to a heightened potential for adverse reactions.

Q: Can Diclo KD be used for dental pain or toothaches?

Yes, Diclo KD is indicated for the short-term relief of mild to moderate acute pain. The drug is indicated for pain following dental procedures such as extractions.

Q: Does taking Diclo KD make you more sensitive to the sun?

Yes, regulatory adverse reaction lists document photosensitivity as a potential side effect of diclofenac. This means the drug may cause an increased sensitivity of the skin to sunlight, making sunburn or rashes more likely.

Q: What is the main reason Diclo KD is generally a prescription drug?

The primary reason for its prescription status is the inherent class risk associated with NSAIDs. Regulatory warnings highlight an increased risk of serious, potentially fatal, cardiovascular thrombotic events (heart attack, stroke) and severe gastrointestinal bleeding and ulceration, which necessitate medical supervision.

Q: Is Diclo KD considered a narcotic or opioid?

No, the official product information classifies Diclo KD as a Nonsteroidal Anti-Inflammatory Drug (NSAID). It is a separate pharmacological class of medication and is not considered a narcotic or an opioid.

Q: How does the potassium component in Diclo KD affect the body?

In addition to facilitating rapid absorption, official warnings state that like other NSAIDs, diclofenac can cause an elevation in serum potassium levels (hyperkalemia). This potential for elevated potassium is a consideration for individuals with certain pre-existing conditions or those using other medications that can also affect potassium levels.

How should Diclo KD be stored and disposed of?

Storage Requirements

Diclo KD must be stored at Controlled Room Temperature, which is officially defined as 20 C to 25 C (68 F to 77 F), with permitted brief temperature excursions. It is mandatory to store the medicine away from heat, moisture, and direct light, and to keep the product from freezing.

The medicine should remain in its original container and be kept tightly closed to protect it from the environment. A crucial safety requirement is that the medication must be stored out of the sight and reach of children.

Handling and Disposal

Outdated or unused medicine should not be kept. For proper disposal, the medicine must not be flushed down the toilet or poured down a drain. The recommended disposal procedure is through an authorized drug take-back program or a DEA-authorized collector.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Diclo KD found in:

A-Z Index: